Upcoming Events
Frontline Conversations
Frontline Conversations: Targeting Compliance Gaps with USP Chapter <797>
Thursday, May 30, 2024 from 1:00 pm - 2:00 pm ET
Read moreWorkshops
Medication Safety Intensive Workshop - August 2024
Thursday, August 8 & Friday, August 9, 2024
Read moreWorkshops
Medication Safety Intensive Workshop - September 2024
Friday, September 20 & Friday, September 27, 2024
Read moreOn Demand Education
ASHP Webinars
Elevating Compliance: Navigating USP <797> with Technology and Standardization
Health systems have worked diligently to ensure that they are in compliance with the revised USP Chapter <797> requirements. This educational activity will demonstrate how health systems of a...
Read moreASHP Webinars
Mind the Gaps: Assessing Your Institution’s Compliance with USP Chapter <797>
Health systems have worked diligently to ensure that they are in compliance with the revised USP Chapter <797> requirements. This educational activity will summarize key revisions to the revi...
Read moreWebinars
Leveraging IV Robotics to Optimize Sterile Compounding Practices to Improve Safety
Learn about the role of IV robotics in the advancement of safety in sterile compounding operations and the steps needed to address perceived barriers for its implementation and use.
Read moreWebinars
Podcasts
Errors Associated with Oxytocin
Intravenous (IV) oxytocin used antepartum is indicated to induce labor in patients with a medical indication to stimulate or reinforce labor in selected cases of uterine inertia and as an adjunct i...
Read moreWebinars
Webinars
Reducing the Risk and Infection Outbreaks from Drug Diversion
Drug diversion is a serious problem that affects patients’ and health professionals’ safety. Patients may suffer from suboptimal therapy if their medications were diverted, receive substandard care...
Read morePodcasts
Podcasts
Errors Associated with Paxlovid
Paxlovid was authorized under the emergency use authorization (EUA) by the US Food and Drug Administration (FDA) in December 2021 and is used for mild-to-moderate coronavirus 2019 (COVID-19) in ad...
Read more